Purchase Order 75N91020P00826

This is a $80,002 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the University of California, San Francisco (UCSF) for the preparation of tissue samples and medical records from never-smoking, Asian-American women with histologically confirmed lung cancer for the SHERLOCK-LUNG study. The study aims to identify exposure-related mutational signatures in lung cancer tumors from never-smoking women worldwide. The...

The U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded a $50,000.00 firm fixed-price purchase order to the Regents of the University of California, San Francisco (UCSF) to obtain historical samples of frozen tumor tissue and adjacent normal lung tissue from never-smoking lung cancer patients, along with accompanying medical documentation and data. This purchase order is part of the NCI's Sherlock-Lung study, an international whole-genome sequencing study of...

This federal contract award, with a ceiling value of $826,870.34, was issued by the National Cancer Institute (NCI) to Northwestern University for a Phase I clinical trial of inhaled iloprost to prevent lung cancer in former smokers. The award is part of the NCI's Cancer Prevention Agent Development Program, which supports early-phase research to evaluate novel cancer prevention agents. Northwestern University, a private research university, is serving as the prime contractor for this work....

The National Cancer Institute (NCI) awarded a $215,944 firm-fixed-price delivery order contract to the University of Southern California (USC) to conduct a Patterns of Care (POC)/Quality of Care Study for non-small cell lung cancer (NSCLC) diagnosed in 2017 and NSCLC and melanoma diagnosed in 2018. This contract is part of the larger Surveillance Epidemiology and End Results (SEER) program IDIQ contract, which allows NCI to issue task orders to USC for various cancer-related research and data...

This is a delivery order contract with a potential value of $66,574.00 awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services National Institutes of Health, to the University of Utah. The contract is for the NCI Patterns of Care (POC)/Quality of Care Study, which will cover diagnosis years 2017 (non-small cell lung cancer) and 2018 (non-small cell lung cancer and melanoma). The contract does not have a set-aside designation. The University of Utah...

This is a firm-fixed price delivery order awarded by the National Cancer Institute, a civilian agency, to the University of Oklahoma Univ Of Oklahoma Health Sciences Center Division. The award, valued at $607,113.00, is for a pre-clinical study to investigate the use of aerosolized bexarotene as a chemopreventive agent against the three major subtypes of lung cancer in mouse models. This work is being performed under the Preclinical Agent Development Assays 2012-2016 indefinite delivery...

This is a $1,097,981.00 firm fixed price delivery order contract awarded by the National Cancer Institute to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for research to evaluate the use of a novel therapy targeting the STAT3 signaling pathway to prevent the development of non-small cell lung cancer in patients with chronic obstructive pulmonary disease. This delivery order is issued under the PREVENT Preclinical Drug...

This is a firm-fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Department of Public Health Connecticut. The $71,681 contract supports the NCI Patterns of Care (POC)/Quality of Care Study for diagnosis years 2017 (non-small cell lung cancer) and 2018 (non-small cell lung cancer and melanoma). This delivery order is issued under the Surveillance Epidemiology and End Results (SEER) indefinite delivery vehicle, which facilitates CDC's...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $58,477 firm fixed price delivery order contract to the Idaho Hospital Association Inc., a non-profit organization, to conduct a Patterns of Care (POC)/Quality of Care Study on non-small cell lung cancer (NSCLC) patients diagnosed in 2017 and NSCLC and melanoma patients diagnosed in 2018. This contract is part of the NCI Patterns of Care (POC)/Quality of Care Study program and will...

The National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, awarded an $849,440 firm fixed price contract to the University of Oklahoma Health Sciences Center under the Prevent Preclinical Drug Development Program. The University will deliver on the stated objective of chemoprevention with aerosolized let-7 microRNA in mouse models of non-small cell lung cancer adenocarcinoma and squamous cell carcinoma. Two subcontracts were issued...